Skip to main content
Erschienen in: Diabetologia 5/2005

01.05.2005 | Article

Heterogeneity in limb fatty acid kinetics in type 2 diabetes

verfasst von: M. Sacchetti, D. B. Olsen, B. Saltin, G. van Hall

Erschienen in: Diabetologia | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

In order to test the hypothesis that disturbances in skeletal muscle fatty acid metabolism with type 2 diabetes are not equally present in the upper and lower limbs, we studied fatty acid kinetics simultaneously across the arm and leg of type 2 diabetic patients (n=6) and matched control subjects (n=7) for 5 h under baseline conditions and during a 4-h hyperinsulinaemic–euglycaemic clamp.

Methods

Limb fatty acid kinetics was determined by means of continuous [U-13C]palmitate infusion and measurement of arteriovenous differences.

Results

The systemic palmitate rate of appearance was 3.6±0.4 and 2.7±0.3 μmol·kg lean body mass−1·min−1 and decreased during the clamp by 26% (p=0.04) and 43% (p<0.01) in the diabetic patients and in the control subjects respectively. At baseline, palmitate uptake across the arm was similar in the two groups, whereas leg palmitate uptake was lower than in the arm in the diabetic patients. During the clamp, palmitate uptake decreased in the arm (−48%, p=0.02) and the leg (−38%, p=0.04) of the control subjects, whereas it decreased in the arm (−30%, p=0.04) but not in the leg of the diabetic patients. Similarly, during the clamp palmitate release was substantially suppressed in the arm (−47%, p<0.01) and the leg of the control subjects (−45%, p<0.01), but only in the arm of the diabetic patients (−45%, p<0.01).

Conclusions/interpretation

The present data indicate that type 2 diabetes is characterised by heterogeneity in the dysregulation of skeletal muscle fatty acid metabolism, with only the leg, but not the arm, showing an impairment of fatty acid kinetics at baseline and during a hyperinsulinaemic–euglycaemic clamp causing a physiological increase in insulin concentration.
Literatur
1.
Zurück zum Zitat Skowronski R, Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM (1991) Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 8:330–333 Skowronski R, Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM (1991) Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 8:330–333
2.
Zurück zum Zitat Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020–1024PubMed Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020–1024PubMed
3.
Zurück zum Zitat Boden G, Jadali F, White J et al (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960–966 Boden G, Jadali F, White J et al (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960–966
4.
Zurück zum Zitat Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMed Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMed
5.
Zurück zum Zitat Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91–98PubMed Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91–98PubMed
6.
Zurück zum Zitat Santomauro AT, Boden G, Silva V et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836–1841 Santomauro AT, Boden G, Silva V et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836–1841
7.
Zurück zum Zitat Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356PubMed Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356PubMed
8.
Zurück zum Zitat Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146–E154 Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146–E154
9.
Zurück zum Zitat Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51:784–789 Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51:784–789
10.
Zurück zum Zitat Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 [Suppl 3]:14–23 Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 [Suppl 3]:14–23
11.
Zurück zum Zitat Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933–941 Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933–941
12.
Zurück zum Zitat Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152PubMed Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152PubMed
13.
Zurück zum Zitat Manson JE, Rimm EB, Stampfer MJ (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778CrossRefPubMed Manson JE, Rimm EB, Stampfer MJ (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778CrossRefPubMed
14.
Zurück zum Zitat Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H (1995) Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44:1010–1020 Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H (1995) Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44:1010–1020
15.
Zurück zum Zitat Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F (2004) Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 53:294–305 Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F (2004) Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 53:294–305
16.
Zurück zum Zitat Hagstrom-Toft E, Qvisth V, Nennesmo I et al (2002) Marked heterogeneity of human skeletal muscle lipolysis at rest. Diabetes 51:3376–3383PubMed Hagstrom-Toft E, Qvisth V, Nennesmo I et al (2002) Marked heterogeneity of human skeletal muscle lipolysis at rest. Diabetes 51:3376–3383PubMed
17.
Zurück zum Zitat Fuller NJ, Laskey MA, Elia M (1992) Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass. Clin Physiol 12:253–266 Fuller NJ, Laskey MA, Elia M (1992) Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass. Clin Physiol 12:253–266
18.
Zurück zum Zitat Radegran G (1997) Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83:1383–1388 Radegran G (1997) Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83:1383–1388
19.
Zurück zum Zitat van Hall G, Gonzalez-Alonso J, Sacchetti M, Saltin B (1999) Skeletal muscle substrate metabolism during exercise: methodological considerations. Proc Nutr Soc 58:899–912 van Hall G, Gonzalez-Alonso J, Sacchetti M, Saltin B (1999) Skeletal muscle substrate metabolism during exercise: methodological considerations. Proc Nutr Soc 58:899–912
20.
Zurück zum Zitat Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118–2124 Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118–2124
21.
Zurück zum Zitat Van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J Physiol 543:1033–1046 Van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J Physiol 543:1033–1046
22.
Zurück zum Zitat Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430 Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430
23.
Zurück zum Zitat Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31:1120–1124 Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31:1120–1124
24.
Zurück zum Zitat Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000–E1006 Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000–E1006
25.
Zurück zum Zitat Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213 Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213
26.
Zurück zum Zitat Miles JM, Wooldridge D, Grellner WJ et al (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52:675–681 Miles JM, Wooldridge D, Grellner WJ et al (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52:675–681
27.
Zurück zum Zitat Kelley DE, Reilly JP, Veneman T, Mandarino LJ (1990) Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 258:E923–E929 Kelley DE, Reilly JP, Veneman T, Mandarino LJ (1990) Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 258:E923–E929
28.
Zurück zum Zitat Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR (2003) Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 285:E354–E362PubMed Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR (2003) Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 285:E354–E362PubMed
29.
Zurück zum Zitat Gaster M, Rustan AC, Aas V, Beck-Nielsen H (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53:542–548 Gaster M, Rustan AC, Aas V, Beck-Nielsen H (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53:542–548
30.
Zurück zum Zitat Meek SE, Nair KS, Jensen MD (1999) Insulin regulation of regional free fatty acid metabolism. Diabetes 48:10–14 Meek SE, Nair KS, Jensen MD (1999) Insulin regulation of regional free fatty acid metabolism. Diabetes 48:10–14
31.
Zurück zum Zitat Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L (1988) Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance. J Clin Endocrinol Metab 67:893–898 Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L (1988) Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance. J Clin Endocrinol Metab 67:893–898
32.
Zurück zum Zitat Dyck DJ, Steinberg G, Bonen A (2001) Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281:E600–E607 Dyck DJ, Steinberg G, Bonen A (2001) Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281:E600–E607
33.
Zurück zum Zitat Luiken JJ, Koonen DP, Willems J et al (2002) Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51:3113–3119 Luiken JJ, Koonen DP, Willems J et al (2002) Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51:3113–3119
34.
Zurück zum Zitat Bonen A, Luiken JJ, Glatz JF (2002) Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 239:181–192 Bonen A, Luiken JJ, Glatz JF (2002) Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 239:181–192
35.
Zurück zum Zitat Hajri T, Abumrad NA (2002) Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22:383–415 Hajri T, Abumrad NA (2002) Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22:383–415
36.
Zurück zum Zitat Bruce CR, Anderson MJ, Carey AL et al (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88:5444–5451 Bruce CR, Anderson MJ, Carey AL et al (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88:5444–5451
37.
Zurück zum Zitat van Hall G, Sacchetti M, Radegran G, Saltin B (2002) Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery. J Physiol 543:1047–1058 van Hall G, Sacchetti M, Radegran G, Saltin B (2002) Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery. J Physiol 543:1047–1058
38.
Zurück zum Zitat Coppack SW, Persson M, Judd RL, Miles JM (1999) Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol 276:E233–E240 Coppack SW, Persson M, Judd RL, Miles JM (1999) Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol 276:E233–E240
39.
Zurück zum Zitat Jensen MD (1997) Lipolysis: contribution from regional fat. Annu Rev Nutr 17:127–139 Jensen MD (1997) Lipolysis: contribution from regional fat. Annu Rev Nutr 17:127–139
40.
Zurück zum Zitat Bolinder J, Kerckhoffs DA, Moberg E, Hagstrom-Toft E, Arner P (2000) Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 49:797–802PubMed Bolinder J, Kerckhoffs DA, Moberg E, Hagstrom-Toft E, Arner P (2000) Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 49:797–802PubMed
41.
Zurück zum Zitat Hagstrom-Toft E, Thorne A, Reynisdottir S et al (2001) Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 50:1604–1611PubMed Hagstrom-Toft E, Thorne A, Reynisdottir S et al (2001) Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 50:1604–1611PubMed
42.
Zurück zum Zitat Sjostrand M, Gudbjornsdottir S, Holmang A, Strindberg L, Ekberg K, Lonnroth P (2002) Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects. J Clin Endocrinol Metab 87:2206–2211CrossRefPubMed Sjostrand M, Gudbjornsdottir S, Holmang A, Strindberg L, Ekberg K, Lonnroth P (2002) Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects. J Clin Endocrinol Metab 87:2206–2211CrossRefPubMed
43.
Zurück zum Zitat Navegantes LC, Sjostrand M, Gudbjornsdottir S, Strindberg L, Elam M, Lonnroth P (2003) Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 88:5515–5520 Navegantes LC, Sjostrand M, Gudbjornsdottir S, Strindberg L, Elam M, Lonnroth P (2003) Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 88:5515–5520
44.
Zurück zum Zitat Jacob S, Hauer B, Becker R et al (1999) Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia 42:1171–1174 Jacob S, Hauer B, Becker R et al (1999) Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia 42:1171–1174
45.
Zurück zum Zitat Stumvoll M, Jacob S, Wahl HG et al (2000) Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85:3740–3745CrossRefPubMed Stumvoll M, Jacob S, Wahl HG et al (2000) Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85:3740–3745CrossRefPubMed
Metadaten
Titel
Heterogeneity in limb fatty acid kinetics in type 2 diabetes
verfasst von
M. Sacchetti
D. B. Olsen
B. Saltin
G. van Hall
Publikationsdatum
01.05.2005
Erschienen in
Diabetologia / Ausgabe 5/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1727-1

Weitere Artikel der Ausgabe 5/2005

Diabetologia 5/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.